Related references
Note: Only part of the references are listed.Untargeted 1H-NMR metabolomics in CSF
Helene Blasco et al.
NEUROLOGY (2014)
Plasma metabolomic biomarker panel to distinguish patients with amyotrophic lateral sclerosis from disease mimics
Kay A. Lawton et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2014)
Metabolomics in Cerebrospinal Fluid of Patients with Amyotrophic Lateral Sclerosis: An Untargeted Approach via High-Resolution Mass Spectrometry
Helene Blasco et al.
JOURNAL OF PROTEOME RESEARCH (2013)
Mechanisms, models and biomarkers in amyotrophic lateral sclerosis
Martin R. Turner et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION (2013)
Smoking, Alcohol Consumption, and the Risk of Amyotrophic Lateral Sclerosis: A Population-based Study
Sonja W. de Jong et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2012)
Biochemical alterations associated with ALS
Kay A. Lawton et al.
AMYOTROPHIC LATERAL SCLEROSIS (2012)
ALS patients with mutations in the SOD1 gene have an unique metabolomic profile in the cerebrospinal fluid compared with ALS patients without mutations
Anna Wuolikainen et al.
MOLECULAR GENETICS AND METABOLISM (2012)
Presymptomatic studies in ALS Rationale, challenges, and approach
Michael Benatar et al.
NEUROLOGY (2012)
Multi-platform characterization of the human cerebrospinal fluid metabolome: a comprehensive and quantitative update
Rupasri Mandal et al.
GENOME MEDICINE (2012)
Energy metabolism in amyotrophic lateral sclerosis
Luc Dupuis et al.
LANCET NEUROLOGY (2011)
Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations
Robert Bowser et al.
NATURE REVIEWS NEUROLOGY (2011)
Disease-Related Changes in the Cerebrospinal Fluid Metabolome in Amyotrophic Lateral Sclerosis Detected by GC/TOFMS
Anna Wuolikainen et al.
PLOS ONE (2011)
An integrated functional genomic study of acute phenobarbital exposure in the rat
Claire L. Waterman et al.
BMC GENOMICS (2010)
Metabolomic analysis of serum by (1) H NMR spectroscopy in amyotrophic lateral sclerosis
Alok Kumar et al.
CLINICA CHIMICA ACTA (2010)
1H-NMR-Based Metabolomic Profiling of CSF in Early Amyotrophic Lateral Sclerosis
Helene Blasco et al.
PLOS ONE (2010)
High metabolic level in patients with familial amyotrophic lateral sclerosis
Benoit Funalot et al.
AMYOTROPHIC LATERAL SCLEROSIS (2009)
Biomarkers in amyotrophic lateral sclerosis
Martin R. Turner et al.
LANCET NEUROLOGY (2009)
The human cerebrospinal fluid metabolome
David S. Wishart et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2008)
Automated alignment of chromatographic data
Thomas Skov et al.
JOURNAL OF CHEMOMETRICS (2006)
Mitochondrial involvement in amyotrophic lateral sclerosis - Trigger or target?
SR Bacman et al.
MOLECULAR NEUROBIOLOGY (2006)
Metabolomic analysis and signatures in motor neuron disease
Steve Rozen et al.
METABOLOMICS (2005)
Hypermetabolism in ALS: Correlations with Clinical and Paraclinical Parameters
Jean-Claude Desport et al.
NEURODEGENERATIVE DISEASES (2005)
On intracellular formation of ethanol and its possible role in energy metabolism
AG Antoshechkin
ALCOHOL AND ALCOHOLISM (2001)
1H-NMR studies of cerebrospinal fluid:: endogenous ethanol in patients with cervical myelopathy
S Meshitsuka et al.
CLINICA CHIMICA ACTA (2001)
El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis
BR Brooks et al.
AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS (2000)